Patent Search Primer – Guidelines from Practitioners
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
"Enlarged" Concept of Novelty: Initial Study
December 2, 2004 DRAFT “ENLARGED ” CONCEPT OF NOVELTY : INITIAL STUDY CON CERNING NOVELTY AND THE PRIOR ART EF FECT OF CERTAIN APPL ICATIONS UNDER DRAFT ARTICLE 8(2) OF THE SPLT prepared by the International Bureau I. SUMMARY 1. The present initial study is submitted upon request of the Standing Committee on the Law of Patents (SCP) at its tenth session, held in Geneva from May 10 to 14, 2004, in order to provide a basis for discussion concerning a possible new novelty concept applicable to th e prior art effect of unpublished earlier applications under Article 8(2) of the draft Substantive Patent Law Treaty (SPLT). The study aims at providing broad background information and at facilitating further substantive discussion in the SCP, and thus addresses not only national and regional laws and practices regarding the prior art effect of earlier applications, but also the policy objectives underlying these different practices. 2. The divergences among national laws and practices in resp ect of the prior art effect of unpublished earlier applications seem to reflect different principles and objectives underlying the prevention of double patenting. Examining a number of national and regional laws and practices, it appears that those differ ent practices correspond mainly to one or more of the following three models: (i) Strict novelty: if a claimed invention is explicitly or inherently disclosed in an earlier application, the earlier application defeats the patentability of the claimed in vention; (ii) Broader novelty: even if the claimed invention is not fully disclosed (explicitly or inherently) in the earlier application, the earlier application defeats the patentability of the claimed invention if the differences between the two are minor (for example, a replacement with a well -known equivalent element); (iii) Novelty and inventive step (non-obviousness): the earlier application defeats the patentability of the claimed invention if the latter lacks either novelty or inventive step (non-obviousness) compared to the earlier application. -
Public Health and Intellectual Property Management: the Challenges on Access to Medicines
Public Health and Intellectual Property management: the challenges on access to medicines Dr. Inthira Yamabhai 1 | Public health, innovation and intellectual property Overview Intellectual property (IP) and implications on access to medicine – Trade Related Aspect of Intellectual Property Rights (TRIPS) – TRIPS+ through trade agreements Sources of information 2 | Different forms of IP Trademark: name under which product is marketed Patent: compound, crystalline forms, process, method of use, etc Protection of undisclosed data: clinical test data Copyright: package insert Design protection: packaging 3 | Patents There is nothing such as a worldwide patent! WIPO Patent Cooperation Treaty allows for worldwide filing, but applicant receives a bundle of national patents; same principle under European Patent Convention WTO TRIPS sets certain minimum standards: – Term: 20 years from filing data – Mandatory for all fields of technology – Criteria: novelty, inventive step, industrial applicability – Flexibilities: e.g. parallel importation and compulsory licensing 4 | One drug = one patent??? "…a key element of life cycle management strategies is to extent patent protection for as long as possible by filing secondary patents to keep generics off the market" (Burdon and Sloper 2003) Sofosbuvir: Expiry without patent term extension(s) • Broad compound patent (Markush) Market 2024 • WO2005003147A2 Authorization US: 2013/14 • Compound patent on prodrug • WO2008121634A2 2028 www.who.int/phi/impl ementation/ip_trade/ip • Crystalline forms _patent_landscapes/e -
Confusing Patent Eligibility
CONFUSING PATENT ELIGIBILITY DAVID 0. TAYLOR* INTRODUCTION ................................................. 158 I. CODIFYING PATENT ELIGIBILITY ....................... 164 A. The FirstPatent Statute ........................... 164 B. The Patent Statute Between 1793 and 1952................... 166 C. The Modern Patent Statute ................ ..... 170 D. Lessons About Eligibility Law ................... 174 II. UNRAVELING PATENT ELIGIBILITY. ........ ............. 178 A. Mayo Collaborative Servs. v. Prometheus Labs............ 178 B. Alice Corp. v. CLS Bank Int'l .......... .......... 184 III. UNDERLYING CONFUSION ........................... 186 A. The Requirements of Patentability.................................. 186 B. Claim Breadth............................ 188 1. The Supreme Court's Underlying Concerns............ 189 2. Existing Statutory Requirements Address the Concerns with Claim Breadth .............. 191 3. The Supreme Court Wrongly Rejected Use of Existing Statutory Requirements to Address Claim Breadth ..................................... 197 4. Even if § 101 Was Needed to Exclude Patenting of Natural Laws and Phenomena, A Simple Statutory Interpretation Would Do So .................... 212 C. Claim Abstractness ........................... 221 1. Problems with the Supreme Court's Test................221 2. Existing Statutory Requirements Address Abstractness, Yet the Supreme Court Has Not Even Addressed Them.............................. 223 IV. LACK OF ADMINISTRABILITY ....................... ....... 227 A. Whether a -
Exploring the Relationship Between State-Of-The-Art, Technological and Commercial Feasibility, and the Restatement’S Reasonable Alternative Design Requirement
“FASTEN YOUR SEAT BELT, ORVILLE!”: EXPLORING THE RELATIONSHIP BETWEEN STATE-OF-THE-ART, TECHNOLOGICAL AND COMMERCIAL FEASIBILITY, AND THE RESTATEMENT’S REASONABLE ALTERNATIVE DESIGN REQUIREMENT RICHARD C. AUSNESS* INTRODUCTION Of course Wilbur never told Orville to fasten his seat belt. Not only did the first Wright Flyer have no seat belts, it did not even have seats!1 Orville steered the Wright Flyer I from a prone position, not sitting up.2 Nor was the Wright brothers’ flying machine equipped with such useful safety features as brakes, landing gear, a radio, ailerons, or even much of a tail.3 In fact, if the truth be told, the Wright brothers’ airplane was a flying deathtrap. The good news for both modern pilots and their passengers is that aircraft technology, including safety technology, has progressed enormously since 1903. Aircraft manufacturers have now incorporated many forms of technology, such as radar, global positioning navigation systems, transponders, radios, anti-lock braking systems, and fire-resistant insulation in order to make their products safer. Unfortunately, progress has not been as impressive in other areas. Consider punch presses. Notwithstanding the fact that these machines cause hundreds of injuries in the workplace each year, many punch presses continue to employ Rube Goldberg-like devices such as “pullbacks” to protect punch press operators from serious injury.4 Why has safety technology improved so dramatically over the last hundred years for airplanes while punch press safety technology apparently has not? One explanation for this curious result is that product manufacturers effectively control the pace of technological development, including the development of safety-related technology by deciding how much to invest in research and development.5 At the same time, the experience of aircraft and punch press * Dorothy Salmon Professor of Law, University of Kentucky College of Law. -
Demythologizing PHOSITA
Osgoode Hall Law Journal Article 3 Volume 47, Number 4 (Winter 2009) Demythologizing PHOSITA - Applying the Non- Obviousness Requirement under Canadian Patent Law to Keep Knowledge in the Public Domain and Foster Innovation Matthew eH rder Follow this and additional works at: http://digitalcommons.osgoode.yorku.ca/ohlj Part of the Intellectual Property Law Commons Article Citation Information Herder, Matthew. "Demythologizing PHOSITA - Applying the Non-Obviousness Requirement under Canadian Patent Law to Keep Knowledge in the Public Domain and Foster Innovation." Osgoode Hall Law Journal 47.4 (2009) : 695-750. http://digitalcommons.osgoode.yorku.ca/ohlj/vol47/iss4/3 This Article is brought to you for free and open access by the Journals at Osgoode Digital Commons. It has been accepted for inclusion in Osgoode Hall Law Journal by an authorized editor of Osgoode Digital Commons. Demythologizing PHOSITA - Applying the Non-Obviousness Requirement under Canadian Patent Law to Keep Knowledge in the Public Domain and Foster Innovation Abstract The uS preme Court of Canada recently revised the doctrine of non-obviousness in a pharmaceutical "selection patent" case, Apotex Inc. v. Sanofi-Synthelabo Canada Inc. Although the Court was cognizant of changes to the same doctrine in the United States and the United Kingdom, a critical flaw in how the doctrine is being applied in Canada escaped its attention. Using content analysis methodology, this article shows that Canadian courts frequently fail to characterize the "person having ordinary skill in the art" (PHOSITA) for the purpose of the obviousness inquiry. The ra ticle argues that this surprisingly common analytical mistake betrays a deep misunderstanding of innovation--one which assumes that actors consult patents to learn about scientific developments, devalues the importance of the public domain, and ignores the industry--specific nature of innovation. -
The United States and Europe at a Crossroads
St. John's Law Review Volume 55 Number 3 Volume 55, Spring 1981, Number 3 Article 2 Design Liabilty and State of the Art: The United States and Europe at a Crossroads Hans-Viggo von Hulsen Follow this and additional works at: https://scholarship.law.stjohns.edu/lawreview This Article is brought to you for free and open access by the Journals at St. John's Law Scholarship Repository. It has been accepted for inclusion in St. John's Law Review by an authorized editor of St. John's Law Scholarship Repository. For more information, please contact [email protected]. DESIGN LIABILITY AND STATE OF THE ART: THE UNITED STATES AND EUROPE AT A CROSSROADS* HANS-VIGGO v. HOLSENt INTRODUCTION Viewed generally, the decade of the 1970's was one in which the American law of products liability showed signs of great uncer- tainty. Though the doctrine of so-called "strict tort liability" in- creasingly was adopted, the courts left significant questions to be resolved later on a case-by-case basis. For example, how "strict" was this liability to be? Would a manufacturer's exercise of reason- able care or even a high degree of prudence avoid "strict liability?" What role is to be played by a manufacturer's compliance with the applicable "state of the art?" Which defenses would be available? How would the new doctrine be applied at the trial level? These and a host of other questions were not conclusively answered dur- ing the last decade. There are signs that in the decade of the 1980's some uncertainty will continue. -
Introduction to Patent Data
Introduction to patent data Gianluca Tarasconi, rawpatentdata.blogspot.com IP introduction Querying patent databases is a process where user can meet pitfalls. Datasets answer exactly what they are asked. In order to ask the correct question some background is needed. IP overview Legal right What for? How? Application and Patents New inventions examination Original creative or Exists Copyright artistic forms automatically* Distinctive identification Use and/or Trade marks of products or services registration Registered External appearance Registration* designs Valuable information Reasonable efforts Trade secrets not known to10 the public to keep secret Worldwide patents filings https://www3.wipo.int/ipstats/ipslinechart by patent office 10 Patent Information (I): Ipad Patent Document front page (USD503889) The patent document is the data source; For statistical purposes the data must, however, be cleaned, normalized and reclassified; You need to be able to query (with queries or user interfaces); The latter is the reason why resources (databases, reports, etc.) where data has been preprocessed are used. 2 Patent front page 2 CAVEAT! Is 1 patent = 1 invention? NO Due to applicant strategy, institutional bias etc 1 patent family = 1 invention 10 * PATENT FAMILY DEFINITION A patent family is "a set of patents taken in various countries to protect a single invention (when a first application in a country – the priority – is then extended to other offices).“ In other words, a patent family is "the same invention disclosed by a common inventor(s) and patented in more than one country.” 10 PATENT FAMILY 10 PATENT FAMILY – from EPO Espacenet 10 CAVEAT 2! Is 1 document number= 1 patent? NO Also application kind defines type of application. -
The European Patent Convention, 3 Md
Maryland Journal of International Law Volume 3 | Issue 2 Article 10 The urE opean Patent Convention Follow this and additional works at: http://digitalcommons.law.umaryland.edu/mjil Part of the International Law Commons, and the International Trade Commons Recommended Citation The European Patent Convention, 3 Md. J. Int'l L. 408 (1978). Available at: http://digitalcommons.law.umaryland.edu/mjil/vol3/iss2/10 This Notes & Comments is brought to you for free and open access by DigitalCommons@UM Carey Law. It has been accepted for inclusion in Maryland Journal of International Law by an authorized administrator of DigitalCommons@UM Carey Law. For more information, please contact [email protected]. THE EUROPEAN PATENT CONVENTION The European Patent Convention' (EPC) is an attempt to simplify European patent law. The Convention provides a procedure for securing a single, European patent,2 which has the effect of a national patent in the signatory nations designated in the application. Through this alternative to national procedures, widespread patent coverage should be easier to obtain. Require- patent, however, are rigorous and its ments for a European 3 attraction is primarily the consolidation of the grant procedures. The EPC establishes several organs to handle the various aspects of the patent application procedure. The European Patent Office (EPO), located in Munich, is the international equivalent of a national patent office. Its administrative divisions are the General Search Division, the Examining Division, and the Opposition Division. The Receiving Section is at The Hague. The first procedural step is the filing of an application at either a national patent office or directly with the EPO.4 The application may be in any of the three official languages (English, French, or German) and the applicant's choice becomes the language of the proceedings.5 The Receiving Section subjects the application to both a preliminary6 and a supplementary formal examination to determine whether it is in proper form and all fees are paid. -
PCT Applicant's Guide – National Phase
DE PCT Applicant’s Guide – National Phase – National Chapter – DE Page 1 GERMAN PATENT AND TRADE MARK OFFICE (DEUTSCHES PATENT- UND MARKENAMT) AS DESIGNATED (OR ELECTED) OFFICE CONTENTS THE ENTRY INTO THE NATIONAL PHASE—SUMMARY THE PROCEDURE IN THE NATIONAL PHASE ANNEXES Fees ............................................................... Annex DE.I National processing request form (patents) .................................. Annex DE.II National processing request form (utility models) .............................. Annex DE.III Declaration concerning the inventor ....................................... Annex DE.IV List of abbreviations: Office: German Patent and Trade Mark Office PatG: Patent Act [Patentgesetz] GebrMG: Utility Model Act [Gebrauchsmustergesetz] IntPatÜbkG: Act on International Patent Conventions [Gesetz über internationale Patentübereinkommen] PatKostG: Patent Costs Act [Patentkostengesetz] PatKostZV: Ordinance on Payment of Patent Costs of the German Patent and Trade Mark Office and the Federal Patent Court [Patentkostenzahlungsverordnung] DPMAV: Ordinance concerning the German Patent and Trade Mark Office [Verordnung über das Deutsche Patent- und Markenamt] (25 March 2021) DE PCT Applicant’s Guide – National Phase – National Chapter – DE Page 3 SUMMARY Designated SUMMARY (or elected) Office DE GERMAN PATENT AND DE TRADE MARK OFFICE Summary of requirements for entry into the national phase Time limits applicable for entry into the Under PCT Article 22(1): 30 months from the priority date national phase: Under PCT Article -
Guidelines for Examination in the European Patent Office
GUIDELINES FOR EXAMINATION IN THE EUROPEAN PATENT OFFICE Published by the European Patent Office Published by the European Patent Office Directorate Patent Law 5.2.1 D-80298 Munich Tel.: (+49-89) 2399-4512 Fax: (+49-89) 2399-4465 Printed by: European Patent Office, Munich Printed in Germany © European Patent Office ISBN 3-89605-074-5 a LIST OF CONTENTS page General Part Contents a 1. Preliminary remarks 1 2. Explanatory notes 1 2.1 Overview 1 2.2 Abbreviations 2 3. General remarks 3 4. Work at the EPO 3 5. Survey of the processing of applications and patents at the EPO 4 6. Contracting States to the EPC 5 7. Extension to states not party to the EPC 5 Part A – Guidelines for Formalities Examination Contents a Chapter I Introduction I-1 Chapter II Filing of applications and examination on filing II-1 Chapter III Examination of formal requirements III-1 – Annex List of Contracting States to the Paris Convention (see III, 6.2) III-20 Chapter IV Special provisions IV-1 Chapter V Communicating the formalities report; amendment of application; correction of errors V-1 Chapter VI Publication of application; request for examination and transmission of the dossier to Examining Division VI-1 Chapter VII Applications under the Patent Cooperation Treaty (PCT) before the EPO acting as a designated or elected Office VII-1 Chapter VIII Languages VIII-1 Chapter IX Common provisions IX-1 Chapter X Drawings X-1 Chapter XI Fees XI-1 Chapter XII Inspection of files; communication of information contained in files; consultation of the Register of European -
Evergreening" Metaphor in Intellectual Property Scholarship
University of Missouri School of Law Scholarship Repository Faculty Publications Faculty Scholarship 2019 The "Evergreening" Metaphor in Intellectual Property Scholarship Erika Lietzan University of Missouri School of Law, [email protected] Follow this and additional works at: https://scholarship.law.missouri.edu/facpubs Part of the Food and Drug Law Commons, Intellectual Property Law Commons, and the Science and Technology Law Commons Recommended Citation Erika Lietzan, The "Evergreening" Metaphor in Intellectual Property Scholarship, 53 Akron Law Review 805 (2019). Available at: https://scholarship.law.missouri.edu/facpubs/984 This Article is brought to you for free and open access by the Faculty Scholarship at University of Missouri School of Law Scholarship Repository. It has been accepted for inclusion in Faculty Publications by an authorized administrator of University of Missouri School of Law Scholarship Repository. For more information, please contact [email protected]. DATE DOWNLOADED: Wed Jan 20 13:42:00 2021 SOURCE: Content Downloaded from HeinOnline Citations: Bluebook 21st ed. Erika Lietzan, The "Evergreening" Metaphor in Intellectual Property Scholarship, 53 AKRON L. REV. 805 (2019). ALWD 6th ed. Lietzan, E. ., The "evergreening" metaphor in intellectual property scholarship, 53(4) Akron L. Rev. 805 (2019). APA 7th ed. Lietzan, E. (2019). The "evergreening" metaphor in intellectual property scholarship. Akron Law Review, 53(4), 805-872. Chicago 7th ed. Erika Lietzan, "The "Evergreening" Metaphor in Intellectual Property Scholarship," Akron Law Review 53, no. 4 (2019): 805-872 McGill Guide 9th ed. Erika Lietzan, "The "Evergreening" Metaphor in Intellectual Property Scholarship" (2019) 53:4 Akron L Rev 805. AGLC 4th ed. Erika Lietzan, 'The "Evergreening" Metaphor in Intellectual Property Scholarship' (2019) 53(4) Akron Law Review 805. -
M&A Strategy
MODULE 06 Patent Information MODULE 06. Patent Information OUTLINE LEARNING POINT 1: Understanding patent information 1. Patent information & Patent documents (1) Patent Information (2) Patent documents 2. Advantages of patent information LEARNING POINT 2: Type of patent information search 1. State‐of‐the‐art & Patentability search (1) State‐of‐the‐art search (2) Patentability search 2. Infringement search 3. Validity search 4. Index or name search LEARNING POINT 3: Method of patent information search 1. Types of patent information databases (1) CD‐ROM (2) Online databases 2. Selection of databases 3. Example of on‐line databases search (1) How to access Full‐Text database (2) How to use a Quick Search page LEARNING POINT 4: Strategic use of patent information 1. In licensing (1) ‘Licensing in’ technology (2) ‘Licensing out’ technology (3) ‘Cross‐licensing’ 2. In Mergers & Acquisitions 3. In Research & Development 4. In Human Resource Management INTRODUCTION Even the latest gadgets get outdated in no time. Umpteen, new or improved models are constantly appearing on the market. Can something be really done to survive this fierce competition? In this module, we look at the role of patent information in protecting a business as well as in helping it to gain a competitive edge. In particular, we are going to deal with what is meant by patent information and why it is important and discuss how patent information may be used including searching patent information and strategically using the results of such a search. LEARNING OBJECTIVES 1. You understand the concept of patent information. 2. You understand how to strategically use patent information.